BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Pharm Country

  Life Sciences Greenhouse of Central PA and Ben Franklin Technology Partners of Central & Northern PA Invest $500,000 in Ocunova Inc.

  This investment will aid in the development and clinical trials of a first-in-class drug candidate for the treatment of diabetic dry eye patients.

  February 5, 2018

   · 

  2 min read
• Genetown

  Blue Earth Diagnostics Announces Presentation at Upcoming ASCO 2018 Genitourinary Cancers Symposium on Fluciclovine (18F) PET/CT Impact on Clinical Management of Recurrent Prostate Cancer

  Blue Earth Diagnostics announced the upcoming presentation of initial results from the FALCON clinical trial (NCT02578940) of fluciclovine (18F) PET/CT, evaluating its impact on patient management in biochemically recurrent prostate cancer patients scheduled for salvage treatment with curative intent.

  February 5, 2018

   · 

  5 min read
• 

  Drug Development

  EyeGate Implodes as Eye Drug Flunks Phase II Test

  EGP-437 demonstrated better clinical performance than vehicle control but did not meet its co-primary endpoints.

  February 5, 2018

   · 

  5 min read
• 

  Business

  Cancer Genetics CEO Steps Down

  The Company’s Board has appointed COO John A. (Jay) Roberts as interim CEO.

  February 5, 2018

   · 

  3 min read
• Business

  Minerva Neurosciences Names Remy Luthringer as Executive Chairman and William Doyle as Lead Independent Director

  Dr. Luthringer, as Executive Chairman of the Board and Chief Executive Officer of Minerva, will continue his close involvement with Minerva’s R&D team in the execution of five late stage clinical trials with three molecules.

  February 5, 2018

   · 

  3 min read
• Genetown

  Brooks Life Sciences Helps Revolutionize Compound Management With the Launch of New FluidX AcoustiX Sample Tube

  Brooks Life Sciences, a global leader in automated solutions for temperature-controlled storage and management of compounds and biological samples, today announced the launch of the Brooks Life Sciences FluidX AcoustiX Sample Tube, developed in partnership with AstraZeneca and Labcyte.

  February 5, 2018

   · 

  4 min read
• Covalon to Showcase Centaur Low Particulate, Lubricious Coating at MD&M West

  MD&M West will take place at the Anaheim Convention Center, from February 6-8, 2018.

  February 5, 2018

   · 

  3 min read
• Business

  Encision Reports Third Quarter Fiscal Year 2018 Results

  Encision today announced financial results for its fiscal 2018 third quarter that ended December 31, 2017.

  February 5, 2018

   · 

  16 min read
• Biotech Bay

  Accuray Retires February 2018 Convertible Notes

  Accuray announced today it has retired all February 2018 convertible notes, including $13M aggregate principal amount of its 3.50% convertible senior notes and $27M aggregate principal amount of its 3.50% Series A convertible senior notes both due February 1, 2018.

  February 5, 2018

   · 

  3 min read
• Genetown

  H3 Biomedicine to Present at 2018 BIO CEO & Investor Conference

  H3 Biomedicine announced that company management will present an overview of the company at the 2018 BIO CEO & Investor Conference on Monday, February 12, 2018, at 9:45 a.m. EST at the New York Marriott Marquis in New York.

  February 5, 2018

   · 

  1 min read